Browsing Institutt for helse og samfunn by Author "Radzeviciene Jurgute, Ruta"

Now showing items 1-4 of 4

  • Clinical presentation, microbiological aetiology and disease course in patients with flu-like illness: a post hoc analysis of randomised controlled trial data 
    Verheij, Theo J. M.; Cianci, Daniela; van der Velden, Alike W.; Christopher, Butler; Bongard, Emily; Coenen, Samuel; Colliers, Annelies; Francis, Nick A.; Little, Paul; Godycki-Cwirko, Maciek; Llor, Carl; Chlabicz, Slawomir; Lionis, Christos; Sundvall, Pär-Daniel; Bjerrum, Lars; De Sutter, Ann; Aabenhus, Rune; Harbin, Nicolay Jonassen; Lindbæk, Morten; Glinz, Dominik; Bucher, Heiner C.; Kovács, Bernadett; Seifert, Bohumil; Radzeviciene Jurgute, Ruta; Touboul Lundgren, Pia; de Paor, Muireann; Matheeussen, Veerle; Goossens, Herman; Margareta, Leven (Journal article / Tidsskriftartikkel / PublishedVersion; Peer reviewed, 2022)
    Background There is little evidence about the relationship between aetiology, illness severity, and clinical course of respiratory tract infections (RTIs) in primary care. Understanding these associations would aid in the ...
  • Cost-effectiveness of adding oseltamivir to primary care for influenza-like-illness: economic evaluation alongside the randomised controlled ALIC4E trial in 15 European countries 
    Li, Xiao; Bilcke, Joke; van der Velden, Alike W.; Bruyndonckx, Robin; Coenen, Samuel; Bongard, Emily; de Paor, Muirrean; Chlabicz, Slawomir; Godycki-Cwirko, Maciek; Francis, Nick; Aabenhus, Rune; Bucher, Heiner C.; Colliers, Annelies; De Sutter, An; Garcia-Sangenis, Ana; Glinz, Dominik; Harbin, Nicolay Jonassen; Kosiek, Katarzyna; Lindbæk, Morten; Lionis, Christos; Llor, Carl; Mikó-Pauer, Réka; Radzeviciene Jurgute, Ruta; Seifert, Bohumil; Sundvall, Pär-Daniel; Touboul Lundgren, Pia; Tsakountakis, Nikolaos; Verheij, Theo J.; Goossens, Herman; Butler, Christopher C.; Beutels, Philippe (Journal article / Tidsskriftartikkel / PublishedVersion; Peer reviewed, 2022)
    Abstract Background Oseltamivir is usually not often prescribed (or reimbursed) for non-high-risk patients consulting for influenza-like-illness (ILI) in primary care in Europe. We aimed to evaluate the ...
  • Direct and Indirect Costs of Influenza-Like Illness Treated with and Without Oseltamivir in 15 European Countries: A Descriptive Analysis Alongside the Randomised Controlled ALIC 4 E Trial 
    Xiao, Li; Bilcke, Joke; van der Velden, Alike; Bongard, Emily; Bruyndonckx, Robin; Sundvall, Pär-Daniel; Harbin, Nicolay Jonassen; Coenen, Samuel; Francis, Nick; Pascale, Bruno; Garcia-Sangenis, Ana; Glinz, Dominik; Kosiek, Katarzyna; Mikó-Pauer, Réka; Radzeviciene Jurgute, Ruta; Seifert, Bohumil; Tsakountakis, Nikolaos; Aabenhus, Rune; Butler, Christopher C; Beutels, Philippe (Journal article / Tidsskriftartikkel / PublishedVersion; Peer reviewed, 2021)
    Background and Objective Influenza-like illness (ILI) leads to a substantial disease burden every winter in Europe; however, oseltamivir is not frequently prescribed to ILI patients in the primary-care setting. An ...
  • Does C-reactive protein predict time to recovery and benefit from oseltamivir treatment in primary care patients with influenza-like illness? A randomized controlled trial secondary analysis 
    Harbin, Nicolay Jonassen; Rystedt, Karin; Lindbæk, Morten; Radzeviciene Jurgute, Ruta; Johan, Westin; Gunnarsson, Ronny; Butler, Christopher C.; van der Velden, Alike W.; Verheij, Theo J. M.; Sundvall, Pär-Daniel (Journal article / Tidsskriftartikkel / PublishedVersion; Peer reviewed, 2021)
    Objective Recovery time and treatment effect of oseltamivir in influenza-like illness (ILI) differs between patient groups. A point-of-care test to better predict ILI duration and identify patients who are most likely ...